Illinois Court Rules for Defendant in Prenatal Monitoring Patent Dispute
Que souhaitez-vous faire ensuite ?
Choisissez votre parcours en fonction de vos besoins actuels :
📋 Résumé de l'affaire
| Nom de l'affaire | Fitch, Even, Tabin and Flannery, LLP v. Dorsey et al. |
| Numéro de dossier | 1:25-cv-03141 |
| Tribunal | Tribunal fédéral de première instance pour le district nord de l'Illinois |
| Durée | Mar 2025 – Feb 2026 335 Days (~11 Months) |
| Résultat | Defendant Win — No Damages |
| Brevets en cause | |
| Produits incriminés | Prenatal physiological monitoring apparatus and method |
Aperçu du dossier
Les parties
⚖️ Demandeur
A well-established Chicago-based intellectual property law firm with a long-standing reputation in patent prosecution and IP portfolio management.
🛡️ Défendeur
Aligned with the development or commercialization of prenatal monitoring technology, with Prenatal-Hope, Inc. focused on maternal-fetal health.
Le brevet en cause
This litigation centered on **U.S. Patent No. US11622705B2**, covering an *apparatus and method for determining physiological parameters of an infant in-utero* — a technology with meaningful implications for prenatal care innovation and the competitive medical monitoring market.
- • US11622705B2 — Apparatus and method for non-invasively determining physiological parameters of an infant in-utero
Developing a prenatal monitoring device?
Check for potential infringement before launch with PatSnap Eureka’s FTO tools.
Le verdict et l'analyse juridique
Résultat
The court entered a verdict **in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc.**, and against plaintiff Fitch, Even, Tabin and Flannery, LLP. No damages were awarded to the plaintiff. This outcome underscores critical lessons for patent prosecutors, IP litigators, and R&D teams operating in the medtech space.
Principales questions juridiques
The verdict favoring the defendants could stem from a finding of non-infringement, invalidity of the asserted claims (e.g., due to anticipation, obviousness, or enablement issues), or a procedural ruling. The case involved a granted utility patent (US11622705B2) with claims scope around in-utero physiological parameter measurement, where claim construction battles frequently center on the scope of method steps and apparatus limitations in medtech.
Freedom to Operate (FTO) Analysis in Prenatal Monitoring
This case highlights crucial IP risks in the rapidly evolving prenatal monitoring sector. Choose your next step:
📋 Comprendre l'impact de cette affaire
Learn about the specific risks and implications from this litigation for medtech.
- View the patent family of US11622705B2
- See which companies are active in fetal monitoring patents
- Understand claim construction patterns in medtech
🔍 Vérifier les risques liés à mon produit
Run a comprehensive FTO analysis for your own medical device or technology.
- Saisissez la description de votre produit ou ses caractéristiques techniques.
- AI identifies potentially blocking patents in medtech
- Obtenir un rapport d'évaluation des risques exploitable
Zone à haut risque
In-utero physiological monitoring methods
Single Patent
US11622705B2 at issue
Efficient Resolution
Case closed in 335 days
✅ Points clés à retenir
Defendant-favorable verdicts in infringement actions can arise from non-infringement, invalidity, or procedural grounds — each requiring distinct litigation preparation.
Rechercher la jurisprudence connexe →The 335-day resolution suggests early dispositive motion practice; study this docket for efficient defense frameworks.
Explorer les précédents →Foire aux questions
The case centered on U.S. Patent No. US11622705B2 (Application No. US17/555256), covering an apparatus and method for determining physiological parameters of an infant in-utero.
The specific basis of termination was not disclosed in publicly available case data. The verdict in favor of defendants Dorsey, Balman, and Prenatal-Hope, Inc. may reflect a finding of non-infringement, patent invalidity, or a procedural ruling. Full analysis requires review of the PACER docket for case 1:25-cv-03141.
The outcome signals that infringement assertions in the fetal monitoring space are contestable and that defendants with strong technical and legal defenses can prevail even against experienced IP plaintiff firms.
Prêt à renforcer votre stratégie en matière de brevets ?
Rejoignez plus de 18 000 professionnels de la propriété intellectuelle qui utilisent PatSnap Eureka pour effectuer des recherches d'antériorité, rédiger des brevets et analyser le paysage concurrentiel avec une précision optimisée par l'IA.
Références
- PACER — U.S. District Court for the Northern District of Illinois, Case 1:25-cv-03141
- USPTO Patent Center — U.S. Patent No. US11622705B2
- Cornell Legal Information Institute — 35 U.S. Code Patent Laws
- PatSnap — Solutions de veille en matière de propriété intellectuelle pour les cabinets d'avocats
Cet article est publié à titre purement informatif et ne constitue en aucun cas un avis juridique. Toutes les informations relatives aux affaires sont tirées de dossiers judiciaires accessibles au public. Pour en savoir plus sur les fonctionnalités de la plateforme, rendez-vous sur PatSnap.